Improving the oral bioavailability of tapentadol via a carbamate prodrug approach: synthesis, bioactivation, and pharmacokinetics

Drug Delivery and Translational Research
Yingchao LiTianhong Zhang

Abstract

Tapentadol suffers from rapid clearance due to extensive metabolism in vivo, which results in low oral bioavailability. In the present study, three novel prodrugs of tapentadol (WWJ01, WWJ02, and WWJ03) were synthesized to improve its metabolic stability and thereby improve its oral bioavailability. They all exhibited good stability in phosphate buffers, simulated gastrointestinal fluids, rat plasma, and intestinal and liver homogenates. Disappointingly, the N,N-diethylcarbamate prodrug of tapentadol (WWJ02) and the N,N-diisopropylcarbamate prodrug of tapentadol (WWJ03) were metabolized into inactive metabolites when incubated with liver microsomes. In contrast, the N,N-dimethylcarbamate prodrug of tapentadol (WWJ01) could be transformed into useful intermediates (M1, M2, and M3), followed by the further release of the active structure (tapentadol) with the addition of plasma. Additionally, the possible biotransformation pathway of WWJ01 was preliminarily studied with a qualitative approach by determining the molecular weight and fragment ions of its metabolic intermediates. Finally, pharmacokinetic studies were carried out to evaluate the oral absorption of WWJ01. WWJ01 showed distinct advantages in oral absorption efficiency,...Continue Reading

References

Dec 14, 2005·Cancer Letters·Floris A de JongRon H J Mathijssen
Dec 8, 2007·European Journal of Drug Metabolism and Pharmacokinetics·Rolf TerlindenKarin Göhler
Jan 26, 2008·Nature Reviews. Drug Discovery·Jarkko RautioJouko Savolainen
Apr 13, 2010·Methods and Findings in Experimental and Clinical Pharmacology·R TerlindenT M Tzschentke
May 6, 2010·Drug Metabolism Reviews·Federica VacondioBernard Testa
May 7, 2010·Current Pharmaceutical Design·J M Férriz, J Vinsová
Jan 5, 2011·Journal of Pain Research·Marc AfilaloDavid Upmalis
Sep 3, 2011·Journal of Pain Research·Nalini VadiveluRaymond Sinatra
Dec 24, 2011·Expert Opinion on Pharmacotherapy·Craig T Hartrick, Jose Rafael Rodríguez Hernandez
Jan 1, 1984·Pharmaceutical Research·O A Olsson, L Å Svensson
Mar 8, 2012·ACS Medicinal Chemistry Letters·Angela RampaVincenzo Di Marzo
Jan 23, 2015·Therapeutics and Clinical Risk Management·Nalini VadiveluJack M Berger
Dec 20, 2015·Journal of Pharmaceutical and Biomedical Analysis·Pei WangZhiguo Yu
Feb 5, 2016·Chemical Research in Toxicology·Xiucai GuoJiang Zheng
Sep 1, 2016·Drug Metabolism Reviews·Joana BarbosaRicardo Jorge Dinis-Oliveira
Nov 9, 2016·European Journal of Medicinal Chemistry·Valentina AbetCarolina Burgos
Nov 16, 2016·Clinics in Liver Disease·Omar Abdulhameed AlmazrooRaman Venkataramanan
Mar 4, 2017·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Michele AzzoliniLucia Biasutto
Apr 24, 2017·European Journal of Medicinal Chemistry·Andrea MattareiLucia Biasutto

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear magnetic resonance

Software Mentioned

DAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.